Abraham N. Oler - Net Worth and Insider Trading
Abraham N. Oler Net Worth
The estimated net worth of Abraham N. Oler is at least $16,375 dollars as of 2024-05-01. Abraham N. Oler is the SVP Corp Dev & Gen Counsel of Traws Pharma Inc and owns about 24,514 shares of Traws Pharma Inc (TRAW) stock worth over $16,375. Details can be seen in Abraham N. Oler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Abraham N. Oler has not made any transactions after 2022-01-28 and currently still holds the listed stock(s).
Transaction Summary of Abraham N. Oler
Abraham N. Oler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Abraham N. Oler owns 1 companies in total, including Traws Pharma Inc (TRAW) .
Click here to see the complete history of Abraham N. Oler’s form 4 insider trades.
Insider Ownership Summary of Abraham N. Oler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRAW | Traws Pharma Inc | 2022-01-28 | VP Corp Dev & Gen Counsel |
Abraham N. Oler Latest Holdings Summary
Abraham N. Oler currently owns a total of 1 stock. Abraham N. Oler owns 24,514 shares of Traws Pharma Inc (TRAW) as of January 28, 2022, with a value of $16,375.
Latest Holdings of Abraham N. Oler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRAW | Traws Pharma Inc | 2022-01-28 | 24,514 | 0.67 | 16,375 |
Holding Weightings of Abraham N. Oler
Abraham N. Oler Form 4 Trading Tracker
According to the SEC Form 4 filings, Abraham N. Oler has made a total of 11 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 1,500 shares on January 28, 2022, which cost Abraham N. Oler around $2,505.
Insider Trading History of Abraham N. Oler
- 1
Abraham N. Oler Trading Performance
GuruFocus tracks the stock performance after each of Abraham N. Oler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Abraham N. Oler is 76.6%. GuruFocus also compares Abraham N. Oler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Abraham N. Oler within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Abraham N. Oler's insider trading performs compared to the benchmark.
Performance of Abraham N. Oler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.92 | | | | | |
| Relative Return to S&P 500(%) | 22.27 | | | | | |
Abraham N. Oler Ownership Network
Abraham N. Oler Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Abraham N. Oler is the VP Corp Dev & Gen Counsel of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , Chief Medical Officer Steven M Fruchtman , and Chief Medical Officer Gelder Mark S. Md .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
Abraham N. Oler Mailing Address
Above is the net worth, insider trading, and ownership report for Abraham N. Oler. You might contact Abraham N. Oler via mailing address: C/o Spectrum Pharmaceuticals, 11500 South Eastern Avenue, Suite 240, Henderson Nv 89052.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
